AKT1 and cancer: As a transcription factor, SOX9 acts as a pleiotropic factor by regulating several key signaling pathways in cancers, such as the Wnt/β-catenin, TGFβ/Smad, PI3K/AKT, and mTOR signaling pathways [38].